Which is the most reliable diagnostic modality for detecting locally residual or recurrent laryngeal squamous cell carcinoma after (chemo)radiotherapy?

Eur Arch Otorhinolaryngol. 2013 Nov;270(11):2787-91. doi: 10.1007/s00405-013-2564-3. Epub 2013 May 21.

Authors

Peter Zbären¹, Remco de Bree, Robert P Takes, Alessandra Rinaldo, Alfio Ferlito

Affiliation

¹ Department of Otorhinolaryngology-Head and Neck Surgery, University Hospital, Berne, Switzerland.

PMID: 23689805
DOI: 10.1007/s00405-013-2564-3

No abstract available

Publication types

Editorial

MeSH terms

Carcinoma, Squamous Cell / diagnosis*
Carcinoma, Squamous Cell / therapy
Chemoradiotherapy
Diffusion Magnetic Resonance Imaging
Fluorodeoxyglucose F18
Humans
Laryngeal Neoplasms / diagnosis*
Laryngeal Neoplasms / therapy
Magnetic Resonance Imaging
Multimodal Imaging
Neoplasm Recurrence, Local / diagnosis*
Neoplasm, Residual
Positron-Emission Tomography
Radiopharmaceuticals
Reproducibility of Results
Tomography, X-Ray Computed

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18